4AB:FRA
AbbVie Common Stock
€253.90
arrow_downward
-0.90%(-2.30) 1D
Oct 21, 8:00:50 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€253.90
High
€253.90
Low
€253.90
Mkt. cap
510.84B
Avg. vol.
73.00
Volume
1.00
52-wk high
€259.60
52-wk low
€167.55
No. of employees
57K
Open
€253.90
High
€253.90
Low
€253.90
Mkt. cap
510.84B
Avg. vol.
73.00
Volume
1.00
52-wk high
€259.60
52-wk low
€167.55
No. of employees
57K
News stories
From web sources and news partners
AD HOC NEWS
·
50 minutes ago
AbbVie cuts third-quarter guidance. AbbVie stock is valued at USD 510.7 billion
The Globe and Mail
·
12 hours ago
AbbVie vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
MarketWatch
·
13 hours ago
AbbVie Inc. stock outperforms competitors on strong trading day
Investor's Business Daily
·
13 hours ago
Can This Small Biotech Enter A $4.3 Billion AbbVie Market? Rapport Rises
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com